| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
Mitomycin-C |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0008 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
| mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.002 |
| mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.005 |
| mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
-0.097 |
0.006 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |